With FDA approval, Celcuity sees big future for its new breast cancer drug
Despite stock dips, the Minnesota biotech firm thinks its innovative therapy and strong results can compete in multibillion dollar markets for cancer treatment.
More from Minnesota Business
Star Tribune Business
Summit Brewing could avoid foreclosure with new lender
Minnesota Business
•
1d ago
Star Tribune Business
Watch the replays of the North Star Summit sessions
Minnesota Business
•
1d ago
Star Tribune Business
Social Security recipients to get 3.6% cost of living boost, an average of $75 per month
Minnesota Business
•
2d ago
MPR Business
Minnesota company leads manufacturing of quartz countertops that California poised to ban
Minnesota Business
•
2d ago
